INS and Insulin resistance: Besides decreasing insulin resistance [5, 135, 136] and improving hepatic insulin sensitivity, sitagliptin seems also to prevent steatosis [137] through GLP-1R signalling in the liver and reduction of endoplasmic reticulum stress [138].